Universal Health Services, Inc. Class B (UHS)

Universal Health Services' stock experienced several notable events between January and July 2025. B of A Securities downgraded UHS to "Underperform" with a price objective of $185.00, and Baird downgraded it to "Neutral." Guggenheim initiated coverage with a "Buy" recommendation, and Morgan Stanley began coverage with an "Equal-Weight" recommendation. The company reported Q1 2025 earnings with an EPS of $4.84, surpassing estimates, and quarterly revenue increased by 6.7%. A director sold 1,097 shares of the stock. The stock price increased by 2.67% from July 15, 2024, to July 14, 2025, but decreased by -10.41% over the last six months. A first-quarter dividend of US$0.20 was announced.

Universal Health Services' acute care services business experiences seasonality, with higher patient volumes and net patient service revenue during the first and fourth quarters due to an increase in illnesses during the winter months.

Universal Health Services, Inc. (UHS) operates in the Healthcare Services sector, focusing on Hospital/Nursing Management and Psychiatric Hospitals. The company provides acute care hospital services and manages behavioral health care facilities, offering a wide range of medical and psychological services, including surgery, internal medicine, obstetrics, emergency care, radiology, oncology, diagnostic care, coronary care, pediatric services, and pharmacy services. UHS also provides specialized treatment programs for mental health conditions, substance abuse disorders, and addiction therapy, along with freestanding emergency departments, outpatient facilities, ambulatory care centers, and telehealth services.

Universal Health Services has an extensive geographic footprint across the United States, Washington, D.C., Puerto Rico, and the United Kingdom. UHS operates over 400 facilities, including 29 acute care hospitals, 331 behavioral health inpatient facilities, 33 freestanding emergency departments, and 27 outpatient facilities and ambulatory care centers in 39 U.S. states. The company strategically positions its facilities in both urban metropolitan regions (65% of facilities) and suburban healthcare markets (35% of facilities).

Universal Health Services has maintained a strong brand reputation, being recognized on the Fortune World's Most Admired List in 2024 and 2025. In July 2025, UHS was ranked #1,090 on the Forbes Global 2000 List. UHS ranked third among the 25 largest health systems in 2021, with a high engagement rating of 98%. The launch of Hippocratic AI's Generative AI Healthcare Agents to assist with post-discharge patient engagement has positively impacted its reputation.

Universal Health Services has a significant institutional ownership presence, with between 1301 and 1303 institutional owners and shareholders holding approximately 65.1 million to 65.6 million shares. Major institutional owners include Vanguard Group Inc, BlackRock, Inc., First Eagle Investment Management, LLC, State Street Corp, Fmr Llc, Geode Capital Management, Llc, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, VFINX - Vanguard 500 Index Fund Investor Shares, and Goldman Sachs Group Inc. Institutional investors hold a substantial portion of the company's stock, with estimates ranging from approximately 52.65% to 80.00%. Insiders own about 5.86% of the stock, while public companies and individual investors hold approximately 14.14% to 27.35%.